Testing time for gene patent as Europe rebels

Testing time for gene patent as Europe rebels

A European rebellion against the patent on a gene for breast cancer held by US company Myriad Genetics is gathering pace. Paris's Curie Institute and the nearby Gustave Roussy Institute will next file a formal objection to the patent, which covers the diagnostic test for the BRCA1 gene.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature (London) 2001-10, Vol.413 (6855), p.443-443
1. Verfasser: Wadman, M
Format: Artikel
Sprache:eng
Schlagworte:
Academies and Institutes
Breast cancer
Criticism
Europe
Genes
Genes, BRCA1
Genetics
Genetics, Medical
Humans
Medical research
Patents as Topic
United States
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A European rebellion against the patent on a gene for breast cancer held by US company Myriad Genetics is gathering pace. Paris's Curie Institute and the nearby Gustave Roussy Institute will next file a formal objection to the patent, which covers the diagnostic test for the BRCA1 gene.
ISSN:0028-0836
1476-4687
DOI:10.1038/35097228